Skip to content
Home / Companies / ABSI ABS
Absci Corp (ABSI) XNAS SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Net insider buying (90d)
Latest ABSI Insider Trades Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Headquarters VANCOUVER, WA
Employees 140
Listed 2021
Exchange XNAS https://www.absci.com SEC filings for ABSI on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market purchase 1 12,900 $149K Grant or award 16 1,374,000 Tax withholding / forfeiture 1 59,896
ABSI Insider Transactions (Form 4) 57 48 Form 4 filings on record, the earliest from Oct 16, 2024, newest first. Filing history page 1 of 2.
Recent ABSI Form 8-K Filings 5
ABSI Insider Trading - FAQ
What is the latest insider trade for ABSI? Absci Corp (ABSI) had 10 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for ABSI runs to 48 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ABSI stock? 1 insider purchase of ABSI was filed in the last 90 days, totaling $149K.
How many insiders are selling ABSI stock? No insider sales of ABSI were filed in the last 90 days. 2 sales are on record for this company.
Where can I see ABSI SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks ABSI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ABSI insider buys? Create a free InsiderAlpha account and press Watch on this page to add ABSI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track ABSI insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free AB Open-market purchase $229K
Market cap $1.49B
P/E ratio -
Dividend yield -
Average volume 4.96M
52 week high $12.06
52 week low $2.24
Today's high $9.30
Today's low $8.60
Open $9.20
Volume 2.51M
Previous close $9.42
Shares outstanding 171.61M Market cap
$1.49B
140 employees
ABSI Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
100% Buying 0% Selling
1 insider purchase totaling $149K against 0 sales totaling $0.
Most-Active ABSI Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 30, 2026 MS Mary T. Szela - Director Open-market purchase Common Stock 12,900 $11.54 $149K
Jun 24, 2026 SM Sean McClain - Officer Tax withholding / forfeiture Common Stock 59,896 $10.08 $603K
Jun 4, 2026 MS Mary T. Szela - Director Grant or award Common Stock 8,400 $0.00 -
Jun 4, 2026 MS Mary T. Szela - Director Grant or award Stock Option (right to buy) 33,200 $0.00 -
Jun 4, 2026 KM Karen K. McGinnis - Director Grant or award Stock Option (right to buy) 39,800 $0.00 -
Jun 4, 2026 MS Mary T. Szela - Director Grant or award Common Stock 10,100 $0.00 -
Jun 4, 2026 MS Mary T. Szela - Director Grant or award Stock Option (right to buy) 39,800 $0.00 -
Jun 4, 2026 MP Menelas N. Pangalos - Director Grant or award Stock Option (right to buy) 39,800 $0.00 -
Jun 4, 2026 HV Houten Frans van - Director Grant or award Stock Option (right to buy) 39,800 $0.00 -
Jun 4, 2026 JS Joseph Sirosh - Director Grant or award Common Stock 10,100 $0.00 -
Jun 4, 2026 JS Joseph Sirosh - Director Grant or award Stock Option (right to buy) 39,800 $0.00 -
May 31, 2026 ZJ Zachariah Jonasson - Officer Tax withholding / forfeiture Common Stock 8,319 $6.75 $56K
Mar 3, 2026 SW Shelby J. Walker - Officer Tax withholding / forfeiture Common Stock 9,825 $2.80 $28K
Mar 2, 2026 SW Shelby J. Walker - Officer Grant or award Stock Option (right to buy) 356,300 $0.00 -
Mar 3, 2026 ZJ Zachariah Jonasson - Officer Tax withholding / forfeiture Common Stock 10,848 $2.80 $30K
Mar 2, 2026 ZJ Zachariah Jonasson - Officer Grant or award Stock Option (right to buy) 534,400 $0.00 -
Mar 2, 2026 TB Todd Bedrick - Officer Grant or award Common Stock 49,600 $0.00 -
Mar 3, 2026 TB Todd Bedrick - Officer Tax withholding / forfeiture Common Stock 5,282 $2.80 $15K
Mar 2, 2026 TB Todd Bedrick - Officer Grant or award Stock Option (right to buy) 195,900 $0.00 -
Mar 2, 2026 SM Sean McClain - Officer Grant or award Common Stock 406,200 $0.00 -
Mar 3, 2026 SM Sean McClain - Officer Tax withholding / forfeiture Common Stock 25,316 $2.80 $71K
Mar 2, 2026 SM Sean McClain - Officer Grant or award Stock Option (right to buy) 1,603,200 $0.00 -
Mar 12, 2026 AB Andreas Busch - Officer Open-market purchase Common Stock 100,000 $2.29 $229K
Mar 2, 2026 MP Menelas N. Pangalos - Director Grant or award Stock Option (right to buy) 22,800 $0.00 -
Mar 3, 2026 SW Shelby J. Walker - Officer Tax withholding / forfeiture Common Stock 9,825 $2.80 $28K
Mar 2, 2026 SW Shelby J. Walker - Officer Grant or award Stock Option (right to buy) 356,300 $0.00 -
Mar 2, 2026 SM Sean McClain - Officer Grant or award Common Stock 406,200 $0.00 -
Mar 3, 2026 SM Sean McClain - Officer Tax withholding / forfeiture Common Stock 25,316 $2.80 $71K
Mar 2, 2026 SM Sean McClain - Officer Grant or award Stock Option (right to buy) 1,603,200 $0.00 -
Mar 2, 2026 TB Todd Bedrick - Officer Grant or award Common Stock 49,600 $0.00 -
Mar 3, 2026 TB Todd Bedrick - Officer Tax withholding / forfeiture Common Stock 5,282 $2.80 $15K
Mar 2, 2026 TB Todd Bedrick - Officer Grant or award Stock Option (right to buy) 195,900 $0.00 -
Mar 3, 2026 ZJ Zachariah Jonasson - Officer Tax withholding / forfeiture Common Stock 10,848 $2.80 $30K
Mar 2, 2026 ZJ Zachariah Jonasson - Officer Grant or award Stock Option (right to buy) 534,400 $0.00 -
Mar 3, 2026 AB Andreas Busch - Officer Tax withholding / forfeiture Common Stock 1,257 $2.80 $4K
Mar 2, 2026 ZJ Zachariah Jonasson - Officer Tax withholding / forfeiture Common Stock 8,307 $2.74 $23K
Feb 2, 2026 SM Sean McClain - Officer Tax withholding / forfeiture Common Stock 26,761 $2.99 $80K
Feb 23, 2026 SM Sean McClain - Officer Option exercise Common Stock 396,399 $1.21 $480K
Feb 23, 2026 SM Sean McClain - Officer Tax withholding / forfeiture Common Stock 267,008 $2.65 $708K
Feb 23, 2026 SM Sean McClain - Officer Option exercise Stock Option (right to buy) 396,399 $0.00 -
Feb 3, 2026 AB Andreas Busch - Officer Tax withholding / forfeiture Common Stock 1,469 $2.99 $4K
Feb 2, 2026 SM Sean McClain - Officer Open-market sale Common Stock 26,761 $2.99 $80K
$NRC
NRC HEALTH
Mary T. Szela - DirectorOpen-market purchase$149K
